Clinical Trials in Ohio

Showing 9421-9440 of 15,929 trials

COMPLETEDNA32 miles

Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)

NCT02258217

Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)

Relapsing Remitting Multiple Sclerosis

OhioHealth30 participantsStarted Jun 2014

Columbus, Ohio, United States

COMPLETEDPhase 232 miles

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

NCT02644668

This study will evaluate the pharmacodynamic (PD) effect of CK-2127107 (hereafter referred to as reldesemtiv) versus placebo on measures of skeletal muscle function or fatigability in patients with Type II, III, or IV spinal muscular atrophy (SMA).

Spinal Muscular Atrophy

Cytokinetics70 participantsStarted Jan 2016

Los Angeles, California, United States • Orange, California, United States • Palo Alto, California, United States +16 more locations

Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

Find Trials by Condition in Ohio

Pancreas Resection With and Without Drains

Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome

A Clinical Trial of KT07 Capsule in the U.S.A

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

AMG 827 in Subjects With Psoriatic Arthritis

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration